Clinical Trial Update: A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating ICP-192 in treated patients with advanced solid tumors possessing FGF/FGFR alterations is ongoing, with the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ICP-192

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 2 | Status: UNKNOWN